PED/PEA-15 inhibits hydrogen peroxide-induced apoptosis in Ins-1E pancreatic beta-cells via PLD-1

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Fiory, Francesca ^a,b   Parrillo, Luca ^a,b   Raciti, Gregory Alexander ^a,b   Zatterale, Federica ^a,b   Nigro, Cecilia ^a,b   Mirra, Paola ^a,b   Falco, Roberta ^a,b   Ulianich, Luca ^a,b   Di Jeso, Bruno ^c   Formisano, Pietro ^a,b   Miele, Claudia ^a,b   Beguinot, Francesco ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF SALENTO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CELL PROTEIN; HYDROGEN PEROXIDE; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PHOSPHOLIPASE D1; PROPRANOLOL; PROTEIN BAD; PROTEIN BCL X; PROTEIN BCL XL; PROTEIN BCL XS; PROTEIN PEA 15; RNA 18S; SCAFFOLD PROTEIN; SULFORHODAMINE B; UNCLASSIFIED DRUG; PEA15 PROTEIN, HUMAN; PHOSPHOLIPASE D; PHOSPHOPROTEIN; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL PROTECTION; CELL STRAIN; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GLUCOSE TOLERANCE; HUMAN; MOUSE; NICK END LABELING; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PROTEIN CLEAVAGE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE; ANIMAL; CYTOLOGY; DRUG EFFECTS; FEMALE; HELA CELL LINE; MALE; METABOLISM;

MUS;

ANIMALS; APOPTOSIS; FEMALE; HELA CELLS; HUMANS; HYDROGEN PEROXIDE; INSULIN-SECRETING CELLS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; PHOSPHOLIPASE D; PHOSPHOPROTEINS; RATS;

EID: 84916912222     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113655     Document Type: Article

References (46)

1. Danziger N, Yokoyama M, Jay T, Cordier J, Glowinski J, et al. (1995) Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate. J Neurochem 64: 1016-25.
2. Fiory F, Formisano P, Perruolo G, Beguinot F (2009) Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism. Am J Physiol Endocrinol Metab 297: E592-601.
3. Renault F, Formstecher E, Callebaut I, Junier MP, Chneiweiss H (2003) The multifunctional protein PEA-15 is involved in the control of apoptosis and cell cycle in Astrocytes. Biochem Pharmacol 66: 1581-8.
4. Condorelli G, Vigliotta G, Cafieri A, Trencia A, Andalò P, et al. (1999) PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene 18: 4409-4415.
5. Condorelli G, Vigliotta G, Iavarone C, Caruso M, Tocchetti CG, et al. (1998) PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J 17: 3858-3866.
6. Hao C, Beguinot F, Condorelli G, Trencia A, Van Meir EG, et al. (2001) Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res 61: 1162-70.
7. Xiao C, Yang BF, Asadi N, Beguinot F, Hao C (2002) Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. J Biol Chem 277: 25020-5.
8. Tsukamoto T, Yoo J, Hwang SI, Guzman RC, Hirokawa Y, et al. (2000) Expression of MAT1/PEA-15 mRNA isoforms during physiological and neoplastic changes in the mouse mammary gland. Cancer Lett 149: 105-13.
9. Stassi G, Garofalo M, Zerilli M, Ricci-Vitiani L, Zanca C, et al. (2005) PED mediates AKT-dependent chemoresistance in human breast cancer cells. Cancer Res 65: 6668-75.
10. Sulzmaier F, Opoku-Ansah J, Ramos JW (2012) Phosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoter. Small GTPases 3: 173-7.
11. Formstecher E, Ramos JW, Fauquet M, Calderwood DA, Hsieh JC, et al. (2001) PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell 1: 239-50.
12. Condorelli G, Trencia A, Vigliotta G, Perfetti A, Goglia U, et al. (2002) Multiple members of the mitogen-activated protein kinase family are necessary for PED/PEA-15 anti-apoptotic function. J Biol Chem 277: 11013-8.
13. Trencia A, Fiory F, Maitan MA, Vito P, Barbagallo AP, et al. (2004) Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15. J Biol Chem 279: 46566-72.
14. Condorelli G, Vigliotta G, Trencia A, Maitan MA, Caruso M, et al. (2001) Protein kinase C (PKC)-alpha activation inhibits PKC-zeta and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells. Diabetes 50: 1244-52.
15. Vigliotta G, Miele C, Santopietro S, Portella G, Perfetti A, et al. (2004) Overexpression of the ped/ pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action. Mol Cell Biol 24: 5005-15.
16. Miele C, Raciti GA, Cassese A, Romano C, Giacco F, et al. (2007) PED/PEA-15 regulates glucoseinduced insulin secretion by restraining potassium channel expression in pancreatic beta-cells. Diabetes 56: 622-33.
17. Karaca M, Magnan C, Kargar C (2009) Functional pancreatic beta-cell mass: involvement in type 2 diabetes and therapeutic intervention. Diabetes Metab 35: 77-84.
18. Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, et al. (2004) Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in Ins-1E insulinoma cells. Endocrinology 145: 667-78.
19. Viparelli F, Cassese A, Doti N, Paturzo F, Marasco D, et al. (2008) Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells. M. J Biol Chem 283: 21769-78.
20. Lombardi A, Ulianich L, Treglia AS, Nigro C, Parrillo L, et al. (2012) Increased hexosamine biosynthetic pathway flux dedifferentiates INS-1E cells and murine islets by an extracellular signalregulated kinase (ERK) 1/2-mediated signal transmission pathway. Diabetologia 55: 141-53.
21. Taniguchi S, Kang L, Kimura T, Niki I (2011) Hydrogen sulphide protects mouse pancreatic b-cells from cell death induced by oxidative stress, but not by endoplasmic reticulum stress. 162: 1171-8.
22. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, et al. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-12.
23. Fagman H, Amendola E, Parrillo L, Zoppoli P, Marotta P, et al. (2011) Gene expression profiling at early organogenesis reveals both common and diverse mechanisms in foregut patterning Dev Biol 359: 163-75.
24. Caruso M, Miele C, Formisano P, Condorelli G, Bifulco G, et al. (1997) In skeletal muscle, glucose storage and oxidation are differentially impaired by the IR1152 mutant receptor. J Biol Chem 272: 7290-7.
25. Sampson SR, Bucris E, Horovitz-Fried M, Parnas A, Kahana S, et al. (2010) Insulin increases H2O2-induced pancreatic beta cell death. Apoptosis 15: 1165-76.
26. Snigdha S, Smith ED, Prieto GA, Cotman CW (2012) Caspase-3 activation as a bifurcation point between plasticity and cell death. Neurosci Bull 28: 14-24.
27. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG (1993) Specific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976-3985.
28. Kim R, Emi M, Tanabe K (2005) Caspase-dependent and-independent cell death pathways after DNA damage. Oncol Rep 14: 595-9.
29. Chan SL, Yu VC (2004) Proteins of the Bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities. Clin Exp Pharmacol Physiol 31: 119-28.
30. Albert D, Pergola C, Koeberle A, Dodt G, Steinhilber D, et al. (2008) The role of diacylglyceride generation by phospholipase D and phosphatidic acid phosphatase in the activation of 5-lipoxygenase in polymorphonuclear leukocytes. J Leukoc Biol 83: 1019-27.
31. Jang J-H, Surh Y-J (2004) Possible role of NF-kappaB in Bcl-xL protection against hydrogen peroxideinduced PC12 cell death. Redox Rep 9: 343-8.
32. Valks DM, Kemp TJ, Clerk A (2003) Regulation of Bcl-xL expression by H2O2 in cardiac myocytes. J Biol Chem 278: 25542-7.
33. Singh M, Sharma H, Singh N (2007) Hydrogen peroxide induces apoptosis in HeLa cells through mitochondrial pathway. Mitochondrion 7: 367-73.
34. Miani M, Barthson J, Colli ML, Brozzi F, Cnop M, et al. (2013) Endoplasmic reticulum stress sensitizes pancreatic beta cells to interleukin-1b-induced apoptosis via Bim/A1 imbalance. Cell Death Dis 4:e701.
35. Ewings KE, Wiggins CM, Cook SJ (2007) Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels Cell Cycle 6: 2236-40.
36. Huang P, Frohman MA (2007) The potential for phospholipase D as a new therapeutic target. Expert Opin Ther Targets 11: 707-16.
37. Yamada M, Banno Y, Takuwa Y, Koda M, Hara A, et al. (2004) Overexpression of phospholipase D prevents actinomycin D-induced apoptosis through potentiation of phosphoinositide 3-kinase signalling pathways in Chinese-hamster ovary cells. Biochem J 378(Pt 2): 649-56.
38. Kim KO, Lee KH, Kim YH, Park SK, Han JS (2003) Anti-apoptotic role of phospholipase D isozymes in the glutamate-induced cell death. Exp Mol Med 35: 38-45.
39. Jang YH, Ahn BH, Namkoong S, Kim YM, Jin JK, et al. (2008) Differential regulation of apoptosis by caspase-mediated cleavage of phospholipase D isozymes. Cell Signal 20: 2198-207.
40. Ma WN, Park SY, Han JS (2010) Role of phospholipase D1 in glucose-induced insulin secretion in pancreatic Beta cells. Exp Mol Med 42: 456-64.
41. Hornberger TA, Chu WK, Mak YW, Hsiung JW, Huang SA, et al. (2006) The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle. Proc Natl Acad Sci U S A 103: 4741-6.
42. Foster DA (2007) Regulation of mTOR by phosphatidic acid? Cancer Res 67: 1-4.
43. Turban S, Hajduch E (2011) Protein kinase C isoforms: mediators of reactive lipid metabolites in the development of insulin resistance. FEBS Lett 585: 269-74.
44. Mohanty S, Huang J, Basu A (2005) Pkc alfa: Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1. Clin Cancer Res 11: 6730-7.
45. Peng Y, Sigua CA, Karsonovich C, Murr MM (2007) Pkc zeta: Protein kinase C-zeta (PKC-zeta) regulates Kupffer cell apoptosis during experimental sepsis. J Gastrointest Surg 11: 1712-21.
46. Schönwasser DC, Marais RM, Marshall CJ, Parker PJ (1998) Activation of the Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Pathway by Conventional, Novel, and Atypical Protein Kinase C Isotypes Mol Cell Biol 18: 790-798.